Daniel Catovsky consultant haematologist
Catovsky, D. (Daniel)
Catovsky, Daniel.
Catovsky, Daniel, 1937-2022
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Catovsky, D.
Catovsky, Daniel (1937- )
Catovsky, D. (Daniel), 1937-
VIAF ID: 263729883 (Personal)
Permalink: http://viaf.org/viaf/263729883
Preferred Forms
-
100 1 _ ‡a Catovsky, D.
-
100 1 _ ‡a Catovsky, D. ‡q (Daniel)
-
100 1 _ ‡a Catovsky, D. ‡q (Daniel)
-
100 1 _
‡a
Catovsky, D.
‡q
(Daniel)
-
100 1 _
‡a
Catovsky, D.
‡q
(Daniel)
-
100 1 _ ‡a Catovsky, D. ‡q (Daniel) (sparse)
-
100 1 _ ‡a Catovsky, D. ‡q (Daniel)
-
100 1 _ ‡a Catovsky, D. ‡q (Daniel), ‡d 1937-
-
100 1 _
‡a
Catovsky, Daniel
-
100 1 _ ‡a Catovsky, Daniel (sparse)
-
100 1 _ ‡a Catovsky, Daniel ‡d (1937- )
-
100 1 _
‡a
Catovsky, Daniel,
‡d
1937-2022
-
100 1 _ ‡a Catovsky, Daniel.
-
100 0 _
‡a
Daniel Catovsky
‡c
consultant haematologist
4xx's: Alternate Name Forms (8)
Works
| Title | Sources |
|---|---|
| Chronic lymphocytic leukemia, c1988: |
|
| Current issues on the management of CLL |
|
| Evidence for human T cell lymphoma-leukemia virus infection of family members of human T cell lymphoma-leukemia virus positive T cell leukemia-lymphoma patients |
|
| Familial Acute Myeloid Leukaemia with Acquired Pelger-Huet Anomaly and Aneuploidy of C Group |
|
| Fludarabine in Lymphoproliferative Disorders: The Royal Marsden Hospital Experience |
|
| Fludarabine phosphate for the treatment of low grade lymphoid malignancy |
|
| Follicular lymphoma. A series of 11 patients with minimal or no treatment and long survival |
|
| Formation of mouse red cell rosettes by "hairy" cells |
|
| Functional analysis of the ATM-p53-p21 pathway in the LRF CLL4 trial: blockade at the level of p21 is associated with short response duration. |
|
| Functional properties of neoplastic T cells in adult T cell lymphoma/leukemia patients from the Caribbean |
|
| Further evidence that germline CEBPA mutations cause dominant inheritance of acute myeloid leukaemia |
|
| G-CSF mobilization of haemopoietic cell populations in SCID mice engrafted with human leukaemia |
|
| Gemcitabine, cisplatin and methylprednisolone chemotherapy (GEM-P) is an effective regimen in patients with poor prognostic primary progressive or multiply relapsed Hodgkin's and non-Hodgkin's lymphoma |
|
| Gene abnormalities in multiple myeloma; the relevance of TP53, MDM2, and CDKN2A |
|
| Granulomatous slack skin disease – disease features and response to pentostatin |
|
| Hairy cell leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. |
|
| Hairy-cell leukaemia with polyarteritis nodosa |
|
| Heterogeneity of breakpoints at the transcriptional co-activator gene, BOB-1, in lymphoproliferative disease. |
|
| High dose methylprednisolone can induce remissions in CLL patients with p53 abnormalities |
|
| Higher expression levels of activation-induced cytidine deaminase distinguish hairy cell leukemia from hairy cell leukemia-variant and splenic marginal zone lymphoma |
|
| Histomorphological study of cellular interactions between stromal and haemopoietic stem cells in normal and leukaemic bone marrow. |
|
| Histopathology of the spleen in T-cell large granular lymphocyte leukemia and T-cell prolymphocytic leukemia: a comparative review |
|
| HTLV-1 envelope sequences from Brazil, the Caribbean, and Romania: clustering of sequences according to geographic origin and variability in an antibody epitope |
|
| HTLV-1 infection in tropical spastic paraparesis: lymphocyte culture and serologic response |
|
| HTLV-I and HTLV-II infections in hematologic disorder patients, cancer patients, and healthy individuals from Rio de Janeiro, Brazil. |
|
| HTLV-I-positive T-cell lymphoma/leukaemia in an African resident in UK |
|
| Hypercalcaemia in T cell acute lymphoblastic leukaemia: report of two cases |
|
| Hypergranular promyelocytic leukemia: correlation between morphology and chromosomal translocations including t(15;17) and t(11;17). |
|
| Hypokalaemia and raised lysozyme levels in acute myeloid leukaemia |
|
| IgVH genes mutation and usage, ZAP-70 and CD38 expression provide new insights on B-cell prolymphocytic leukemia (B-PLL) |
|
| Immunoblastic transformation of a Sezary syndrome in a black Caribbean patient without evidence of HTLV-I. |
|
| Immunoglobulin gene rearrangements in hairy cell leukemia and other chronic B cell lymphoproliferative disorders. |
|
| Immunological reconstitution after bone marrow transplant with Campath-1 treated bone marrow |
|
| Immunoreactive calcitonin in leukaemia |
|
| In vitro activation of leukaemic B cells by interleukin-4 and antibodies to CD40. |
|
| Incomplete Reiter's syndrome following chemotherapy of acute myeloid leukaemia |
|
| Increase in 2',5'-oligoadenylate synthetase caused by deoxycoformycin in hairy cell leukaemia |
|
| Increase of T lymphocytes in the spleen in Hodgkin's disease. |
|
| Infection of leukaemic B lymphocytes by Epstein Barr virus. |
|
| Inherited genetic susceptibility to monoclonal B-cell lymphocytosis |
|
| Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion. |
|
| Inhibitory effect of simvastatin on the proliferation of human myeloid leukaemia cells in severe combined immunodeficient (SCID) mice |
|
| Intensive induction and consolidation chemotherapy for adults and children with acute myeloid leukaemia (AML) joint AML trial 1982-1985 |
|
| Intracytoplasmic inclusions in B prolymphocytic leukaemia: ultrastructural, cytochemical, and immunological studies |
|
| Inversions and tandem translocations involving chromosome 14q11 and 14q32 in T-prolymphocytic leukemia and T-cell leukemias in patients with ataxia telangiectasia |
|
| Isolated bone marrow involvement in diffuse large B cell lymphoma: a report of three cases with review of morphological, immunophenotypic and cytogenetic findings |
|
| The leukemic cell |
|
| The lymphoid leukaemias |
|
| A novel human macrophage-activating factor: distinction from interferon-gamma (IFN-gamma) and granulocyte-macrophage colony-stimulating factor (GMCSF). |
|
| A novel monoclonal antibody BI-3C5 recognises myeloblasts and non-B non-T lymphoblasts in acute leukaemias and CGL blast crises, and reacts with immature cells in normal bone marrow |
|
| Postgraduate haematology |
|
| A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients |
|
| The Third european tutorial on haematopathology |
|
| An unusual variant of T-CLL: evidence for the existence of a hitherto unrecognized T cell subset |
|
